We are live on ! Find out more
LUMO

Lumos Pharma, Inc. Common Stock
LUMO

Delisted

LUMO was delisted on the 11th of December, 2024.

Back to rankings

128 hedge funds and large institutions have $358M invested in Lumos Pharma, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 28 increasing their positions, 36 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

242% more call options, than puts

Call options by funds: $49.1M | Put options by funds: $14.3M

147% more capital invested

Capital invested by funds: $145M → $358M (+$213M)

83% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 18

5% more funds holding

Funds holding: 122 → 128 (+6)

22% less repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 36

Holders
128
Holders Change
+6
Holders Change %
+4.92%
% of All Funds
3.19%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
33
Increased
28
Reduced
36
Closed
18
Calls
$49.1M
Puts
$14.3M
Net Calls
+$34.7M
Net Calls Change
+$24.1M

Top Buyers

1
BlackRock
BlackRock
New York
+$29.8M
2
DCM
Driehaus Capital Management
Illinois
+$3.38M
3
CCI
Columbus Circle Investors
+$3.31M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$3.16M
5
EI
EAM Investors
California
+$3.04M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$6.98M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2.71M
3
BIM
Bogle Investment Management
Massachusetts
-$2.53M
4
Renaissance Technologies
Renaissance Technologies
New York
-$1.55M
5
TC
TFS Capital
Pennsylvania
-$1.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
First Eagle Investment Management
1
First Eagle Investment Management
New York
$55.4M +$2.7M +18,889 +8%
O
2
OrbiMed
New York
$48M – – –
BlackRock
3
BlackRock
New York
$45.4M +$29.8M +208,877 +75,136%
Vanguard Group
4
Vanguard Group
Pennsylvania
$23.1M +$810K +5,668 +6%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$21.8M – – –
Franklin Resources
6
Franklin Resources
California
$12.4M – – –
State Street
7
State Street
Massachusetts
$9.32M -$692K -4,843 -10%
CCI
8
Columbus Circle Investors
$8.27M +$3.31M +23,202 +156%
Northern Trust
9
Northern Trust
Illinois
$6.92M +$127K +887 +3%
Goldman Sachs
10
Goldman Sachs
New York
$5.44M +$2.18M +15,278 +156%
DCM
11
Driehaus Capital Management
Illinois
$5.13M +$3.38M +23,638 New
TA
12
Teachers Advisors
New York
$5.01M +$96K +672 +3%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$4.88M +$1.2M +8,401 +60%
SBH
14
Segall Bryant & Hamill
Illinois
$4.86M -$35K -245 -1%
Balyasny Asset Management
15
Balyasny Asset Management
Illinois
$4.8M +$3.16M +22,137 New
Geode Capital Management
16
Geode Capital Management
Massachusetts
$4.65M +$552K +3,866 +22%
EI
17
EAM Investors
California
$4.62M +$3.04M +21,311 New
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$4.49M +$1.16M +8,120 +65%
Wells Fargo
19
Wells Fargo
California
$3.93M +$74.6K +522 +3%
Deutsche Bank
20
Deutsche Bank
Germany
$3.54M -$586K -4,099 -20%
QI
21
QS Investors
New York
$3.47M – – –
Ameriprise
22
Ameriprise
Minnesota
$3.45M +$2.27M +15,914 New
MWNA
23
Marshall Wace North America
New York
$2.58M +$1.7M +11,934 New
Millennium Management
24
Millennium Management
New York
$2.27M -$6.98M -48,860 -82%
TCIM
25
TIAA CREF Investment Management
New York
$2.27M -$37.7K -264 -2%
1
2 3 4 5

LUMO Hedge Fund Activity: Q1 2017 in Review

128 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q1 2017, worth a combined $358M — up 147% from $145M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new LUMO positions and 18 closed out — a net gain of 15 holders — while 28 added to existing stakes and 36 trimmed.

The largest buyer was BlackRock, adding an estimated $29.8M. The largest seller was Millennium Management, cutting an estimated $6.98M.

  • 128 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q1 2017, up from 122 in Q4 2016.
  • Funds reported $358M of Lumos Pharma, Inc. Common Stock stock for Q1 2017, up 147% quarter-over-quarter.
  • 33 funds opened new Lumos Pharma, Inc. Common Stock positions in Q1 2017 and 18 closed out, a net change of +15 holders.
  • The largest Lumos Pharma, Inc. Common Stock buyer in Q1 2017 was BlackRock, an estimated $29.8M added.
  • The largest Lumos Pharma, Inc. Common Stock seller in Q1 2017 was Millennium Management, an estimated $6.98M sold.

Based on aggregated 13F filings for Q1 2017.